These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6473112)

  • 1. European system for reporting of adverse reactions and drug defects--second report 1982-1983.
    Nuklearmedizin; 1984 Apr; 23(2):107-8. PubMed ID: 6473112
    [No Abstract]   [Full Text] [Related]  

  • 2. The system for "reporting of adverse reactions and drug defects" (1980-1982)--first report.
    Nuklearmedizin; 1982 Dec; 21(6):274-7. PubMed ID: 7167391
    [No Abstract]   [Full Text] [Related]  

  • 3. European system for reporting of adverse reactions and drug defects: second report 1982-1983.
    Eur J Nucl Med; 1984; 9(8):388-9. PubMed ID: 6489373
    [No Abstract]   [Full Text] [Related]  

  • 4. European system for reporting of adverse reactions and drug defects. Fourth report: 1986.
    J Nucl Med Allied Sci; 1988; 32(1):58-60. PubMed ID: 3404266
    [No Abstract]   [Full Text] [Related]  

  • 5. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
    Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classification and profile of adverse drug effects].
    Cordonnier M
    Bull Soc Belge Ophtalmol; 2007; (304):15-6. PubMed ID: 17718223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Zealand Committee on adverse drug reactions: sixteenth annual report 1981.
    McQueen EG
    N Z Med J; 1982 Apr; 95(705):230-3. PubMed ID: 6953361
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular adverse drug reactions and the National Registry of Drug-Induced Ocular Side Effects.
    Fraunfelder FW
    Insight; 2004; 29(2):7-11. PubMed ID: 15709350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacoepidemiology].
    Hallas J; Sørensen HT
    Ugeskr Laeger; 2005 May; 167(20):2186-90. PubMed ID: 15987081
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Medical Products Agency suggests improved drug safety follow-ups. New grasps of better knowledge and adverse effects reporting].
    Sjölin-Forsberg G; Lindeskog B; Lundqvist KM; Feltelius N; Alvan G
    Lakartidningen; 2007 Apr 18-24; 104(16):1226-9. PubMed ID: 17536352
    [No Abstract]   [Full Text] [Related]  

  • 12. European commission consultation on pharmacovigilance.
    Waller P; Beard K; Egberts T; Evans S; Hallas J; Hasford J; Laporte JR; Moore N; Shakir S; Sturkenboom M
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):108-9. PubMed ID: 18058839
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 14. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1999.
    Hesslewood SR
    Eur J Nucl Med; 2001 Feb; 28(2):BP2-8. PubMed ID: 11303900
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions to antibiotics and major antibiotic drug interactions.
    Novotný J; Novotný M
    Gen Physiol Biophys; 1999 Oct; 18 Spec No():126-39. PubMed ID: 10703731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to radiopharmaceuticals: incidence in 1978, and associated symptoms. Report of the Adverse Reactions Subcommittee of the Society of Nuclear Medicine.
    Rhodes BA; Cordova MA
    J Nucl Med; 1980 Nov; 21(11):1107-10. PubMed ID: 7431113
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy exposure registries: academic opportunities and industry responsibility.
    Wyszynski DF
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):93-101. PubMed ID: 19107953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting of adverse drug reactions.
    Soletsky LM
    Postgrad Med; 1997 Jul; 102(1):35-6. PubMed ID: 9254389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.